Endocannabinoid System Components: Overview and Tissue Distribution.

  title={Endocannabinoid System Components: Overview and Tissue Distribution.},
  author={Neal Joshi and Emmanuel Shan Onaivi},
  journal={Advances in experimental medicine and biology},
Marijuana/cannabinoid research has been transformed into mainstream science during the last half-century. Evidence based research and remarkable biotechnological advances demonstrate that phytocannabinoids and endocannabinoid (eCBs) acting on cannabinoid receptors (CBRs) regulate various aspects of human physiological, behavioral, immunological and metabolic functions. The distribution and function of the components of the endocannabinoid system (ECS) in the central nervous system (CNS) and… 

Cannabinoids and Breast Cancer

Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

The evidence accumulated so far at the preclinical level supports the need to soon move towards the patients and initiate clinical trials to confirm the potential of cannabinoid‐based medicines as disease modifiers in ALS.

The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin

Normal equine skin, including equine epidermal keratinocytes and dermal fibroblast‐like cells, all exhibited constant gene and protein expression of CBRs, representing a starting point for developing and translating new veterinary medicine‐based pharmacotherapies using ECS as a possible target.

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders

Its non-psychoactive effect makes theCB2R a potential target for treating CNS disorders; however, a better understanding of the fundamental pharmacology of CB2R activation is essential for the design of novel therapeutic strategies.

Cannabidiol modulation of oxidative stress and signalling

A body of literature indicates that CBD can regulate redox function at multiple levels, with a range of downstream effects on cells and tissues, however, pro-oxidant capacity of CBD has been reported, and hence caution must be applied when considering CBD from a therapeutic standpoint.

Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review

Preclinical studies using cannabis-based therapies in animal models have shown that cannabinoids can alleviate the development of osteoarthritis, prevent osteoporosis, reduce cancer-induced osteolytic destruction, and improve fracture healing, highlighting the therapeutic potential of CBs for human bone diseases.

Cannabinoid and Marijuana Neurobiology

This chapter provides an overview of the endocannabinoid signaling system, how THC affects the neurobiology of cannabinoids, and implications of this newly found knowledge for public health and public policy.

Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System

This review summarizes the molecular mechanisms of action and biological functions of ABHD6, particularly its mechanism of action in the pathogenesis of neurological diseases, and provides a theoretical basis for new pharmacological interventions via targeting of AB HD6.

Role of Gut Microbiota in Cannabinoid-Mediated Suppression of Inflammation

It is discussed how cannabinoid-mediated induction of microbial secondary bile acids, short chain fatty acids, and indole metabolites, produced in the gut, can suppress inflammation even in distal organs.

Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis

Targeting and modulating the ECS with cannabinoids or cannabinoid derivatives may represent a major disease-modifying medical advancement to achieve successful treatment for MetS and certain cardiovascular diseases.



Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System

An overview of the available skin-relevant endo- and phytocannabinoid literature is given with a special emphasis on the putative translational potential, and to highlight promising future research directions as well as existing challenges.

Endocannabinoid signaling at the periphery: 50 years after THC.

Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases

The ES is an emerging target for drug discovery, because it is involved in the regulation of many cellular and physiological functions and may hold tremendous therapeutic potential in various conditions mentioned in this review.

Endocannabinoid system, pharmacogenomics and response to therapy.

Recent advances in understanding the biological actions of marijuana, cannabinoids and eCBs are unraveling the genetic basis of marijuana use, with functional implication for cannabinoid pharmacotherapy.

CB2: a cannabinoid receptor with an identity crisis

This review will discuss the reported tissue distribution of CB2 with a focus on CB2 in neurons, particularly those in the central nervous system as well as the implications of that presence.

Cannabinoids and mitochondria

Historical and recent evidence of the cannabinoid impact on mitochondrial functions in peripheral and central organs of the body is summarized.

Expression of the Endocannabinoid Receptors in Human Fascial Tissue

This is the first demonstration that the fibroblasts of the muscular fasciae express CB1 and CB2, which could help to provide a description of cannabinoid receptors distribution and to better explain the role of fasciae as pain generator and the efficacy of some fascial treatments.

CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity

Current understanding of CNR2 genomic structure, its polymorphic nature, subtype specificity, from mice to human subjects, and its variants that confer vulnerabilities to neuropsychiatric disorders beyond neuro-immuno-cannabinoid activity are summarized.